A novel drug reduces the monthly frequency of seizure in adults with focal epilepsy

Post author:
Post published:October 11, 2023
Post category:uncategorized

The effect of a novel Kv7.2/Kv7.3 potassium channel opener XEN1101 in reducing monthly seizure frequency in adults.

Empowering individuals with knowledge, fostering healthier lifestyles, and fostering a community dedicated to diabetes awareness and prevention. Together, we’re shaping a healthier future.

Helpful Links

Subscribe To Us

By submitting via this part of the website you are granting us permission to store and process your data according to our Standard privacy policy

UPCOMING EVENTS

You Might Also Like

New institute to integrate food-based nutrition interventions into health care

Efficacy of acupuncture in improving sleep quality for Parkinson’s patients

More than 20,000 volunteers join effort to accelerate dementia drug development

Helpful Links

Subscribe To Us